Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Nov 28:15:8353-8363.
doi: 10.2147/IJGM.S386375. eCollection 2022.

Traditional Chinese Medicine in Treatment of COVID-19 and Viral Disease: Efficacies and Clinical Evidence

Xue Ding  1 , Lei-Lei Fan  2 , Shi-Xi Zhang  3 , Xiu-Xia Ma  4 , Peng-Fei Meng  4 , Liang-Ping Li  5 , Ming-Yan Huang  5 , Jia-Le Guo  5 , Peng-Zhan Zhong  5 , Li-Ran Xu  5
Affiliations
Review

Traditional Chinese Medicine in Treatment of COVID-19 and Viral Disease: Efficacies and Clinical Evidence

Xue Ding et al. Int J Gen Med. .

Abstract

Coronavirus disease 2019 (COVID-19) remains an uncontained, worldwide pandemic. While battling the disease in China, the Chinese government has actively promoted the use of traditional Chinese medicine, and many studies have been conducted to determine the efficacy of traditional Chinese medicine for treating COVID-19. The present review discusses the effectiveness and safety of traditional Chinese medicine in curing COVID-19 and provides clinical evidence from all confirmed cases in China. Applications of traditional Chinese medicine and specific recipes for treating other viral infections, such as those caused by severe acute respiratory syndrome coronavirus and influenza A viruses (including H1N1), are also discussed. Studies have reported that traditional Chinese medicine treatment plays a significant role in improving clinical symptoms. Therefore, further investigation may be of high translational value in revealing novel targeted therapies for COVID-19.

Keywords: acute respiratory syndrome coronavirus; clinical evidence; coronavirus disease-2019; influenza A viruses; traditional Chinese medicine.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Similar articles

See all similar articles

Cited by

References

    1. Du HX, Zhou HF, Wan HF, et al. Antiviral effects and mechanisms of Yinhuapinggan granule against H1N1 influenza virus infection in RAW264.7 Cells. Inflammopharmacology. 2018;26:1455–1467. doi:10.1007/s10787-018-0457-1 - DOI - PubMed
    1. World Healthe Organization. WHO Director-General as Guest Lecture at Robert S. McNamara Lecture on War and Peace, Harvard Kennedy School - 25 February 2022. World Healthe Organization; 2022.
    1. Huang Y, Yang C, Xu XF, Xu W, Liu SW. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol Sin. 2020;41:1141–1149. doi:10.1038/s41401-020-0485-4 - DOI - PMC - PubMed
    1. Huang K, Zhang P, Zhang Z, et al. Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: efficacies and mechanisms. Pharmacol Ther. 2021;225:107843. doi:10.1016/j.pharmthera.2021.107843 - DOI - PMC - PubMed
    1. China NHCotPsRo. Transcript of Press Conference on March 17, 2020; Vol. 2022, 2022.

LinkOut - more resources